Headlines

PennyMac Mortgage Investment Trust And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – PennyMac Mortgage Investment Trust (PMT), Titan Machinery (TITN), Texas Roadhouse (TXRH) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. PennyMac Mortgage Investment Trust (PMT)

78% sales growth and 7.63% return on equity

PennyMac Mortgage Investment Trust, a specialty finance company, primarily invests in mortgage-related assets in the United States. It operates through four segments: Credit Sensitive Strategies, Interest Rate Sensitive Strategies, Correspondent Production, and Corporate. The company's Credit Sensitive Strategies segment invests in credit risk transfer (CRT) agreements, CRT securities, distressed loans, real estate, and non-agency subordinated bonds. Its Interest Rate Sensitive Strategies segment engages in investing in mortgage servicing rights, excess servicing spreads, and agency and senior non-agency mortgage-backed securities (MBS), as well as related interest rate hedging activities. The company's Correspondent Production segment is involved in purchasing, pooling, and reselling newly originated prime credit residential loans directly or in the form of MBS. PNMAC Capital Management, LLC acts as the manager of PennyMac Mortgage Investment Trust. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its shareholders. PennyMac Mortgage Investment Trust was founded in 2009 and is headquartered in Westlake Village, California.

Earnings Per Share

As for profitability, PennyMac Mortgage Investment Trust has a trailing twelve months EPS of $0.61.

PE Ratio

PennyMac Mortgage Investment Trust has a trailing twelve months price to earnings ratio of 20.13. Meaning, the purchaser of the share is investing $20.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.63%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 97%, now sitting on 513.17M for the twelve trailing months.

Moving Average

PennyMac Mortgage Investment Trust’s value is below its 50-day moving average of $12.31 and under its 200-day moving average of $12.77.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 2900% and 542.9%, respectively.

Sales Growth

PennyMac Mortgage Investment Trust’s sales growth is negative 27.2% for the present quarter and 78% for the next.

2. Titan Machinery (TITN)

24.4% sales growth and 21.97% return on equity

Titan Machinery Inc. owns and operates a network of full-service agricultural and construction equipment stores in the United States and Europe. It operates through three segments: Agriculture, Construction, and International. The company sells new and used equipment, including agricultural and construction equipment manufactured under the CNH Industrial family of brands, as well as equipment from various other manufacturers. Its agricultural equipment includes machinery and attachments for use in the production of food, fiber, feed grain, and renewable energy; and home and garden applications, as well as maintenance of commercial, residential, and government properties. The company's construction equipment comprises heavy construction machinery, light industrial machinery for commercial and residential construction, road and highway construction machinery, and energy and forestry operations equipment. It also sells maintenance and replacement parts. In addition, the company offers repair and maintenance services that include warranty repairs, off-site and on-site repair services, scheduling off-season maintenance services, and notifying customers of periodic service requirements; and training programs to customers. Further, it rents equipment; and provides ancillary equipment support services, such as equipment transportation, global positioning system signal subscriptions and other precision farming products, farm data management products, and CNH Industrial finance and insurance products. The company operates in Colorado, Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Wisconsin, and Wyoming, the United States; and Bulgaria, Germany, Romania, Serbia, and Ukraine, Europe. Titan Machinery Inc. was founded in 1980 and is headquartered in West Fargo, North Dakota.

Earnings Per Share

As for profitability, Titan Machinery has a trailing twelve months EPS of $5.41.

PE Ratio

Titan Machinery has a trailing twelve months price to earnings ratio of 4.74. Meaning, the purchaser of the share is investing $4.74 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.97%.

Yearly Top and Bottom Value

Titan Machinery’s stock is valued at $25.62 at 01:22 EST, way below its 52-week high of $47.87 and above its 52-week low of $24.48.

Volume

Today’s last reported volume for Titan Machinery is 239784 which is 33.91% above its average volume of 179062.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 16.4% and positive 16% for the next.

3. Texas Roadhouse (TXRH)

12.3% sales growth and 29.12% return on equity

Texas Roadhouse, Inc., together with its subsidiaries, operates casual dining restaurants in the United States and internationally. The company operates and franchises Texas Roadhouse and Bubba's 33 restaurants. As of December 29, 2020, it operated 537 domestic restaurants and 97 franchise restaurants. Texas Roadhouse, Inc. was founded in 1993 and is based in Louisville, Kentucky.

Earnings Per Share

As for profitability, Texas Roadhouse has a trailing twelve months EPS of $4.44.

PE Ratio

Texas Roadhouse has a trailing twelve months price to earnings ratio of 22.06. Meaning, the purchaser of the share is investing $22.06 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.12%.

Sales Growth

Texas Roadhouse’s sales growth is 12.8% for the current quarter and 12.3% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Texas Roadhouse’s EBITDA is 60.7.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Sep 4, 2023, the estimated forward annual dividend rate is 2.11 and the estimated forward annual dividend yield is 2.23%.

4. The Travelers Companies (TRV)

10.5% sales growth and 10.95% return on equity

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States and internationally. It operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; and national property and other that serve large and mid-sized customers, commercial trucking industry, and agricultural businesses, as well as markets and distributes its products through brokers, wholesale agents, and program managers. The Bond & Specialty Insurance segment provides surety, fidelity, management and professional liability, and other property and casualty coverages and related risk management services through independent agencies and brokers. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners' insurance to individuals through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.

Earnings Per Share

As for profitability, The Travelers Companies has a trailing twelve months EPS of $9.26.

PE Ratio

The Travelers Companies has a trailing twelve months price to earnings ratio of 18.14. Meaning, the purchaser of the share is investing $18.14 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.95%.

Moving Average

The Travelers Companies’s worth is above its 50-day moving average of $163.44 and below its 200-day moving average of $173.33.

5. ExlService Holdings (EXLS)

9.4% sales growth and 22.55% return on equity

ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.

Earnings Per Share

As for profitability, ExlService Holdings has a trailing twelve months EPS of $1.

PE Ratio

ExlService Holdings has a trailing twelve months price to earnings ratio of 29.12. Meaning, the purchaser of the share is investing $29.12 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.55%.

Moving Average

ExlService Holdings’s value is higher than its 50-day moving average of $28.54 and under its 200-day moving average of $31.22.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 9.7% and 12.9%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 1.54B for the twelve trailing months.

Volume

Today’s last reported volume for ExlService Holdings is 2926770 which is 169.03% above its average volume of 1087860.

6. Yelp (YELP)

9.4% sales growth and 6% return on equity

Yelp Inc. operates a platform that connects consumers with local businesses in the United States and internationally. The company's platform covers various local business categories, including restaurants, shopping, beauty and fitness, health, and other categories, as well as home, local, auto, professional, pets, events, real estate, and financial services. It provides free and paid advertising products to businesses, which include cost-per-click search advertising and multi-location Ad products, as well as enables businesses to deliver targeted search advertising to local audiences; and business listing page products. The company also offers other services comprising Yelp Guest Manager, a subscription-based suite of front-of-house management tools for restaurants, nightlife and certain other venues, which include online reservations, a waitlist management solution that allows consumers to check wait times and join waitlists remotely as well as through hostless kiosks, and seating and server rotation management tools; Yelp Knowledge program that offers business owners local analytics and insights through access to its historical data and other proprietary content; and Yelp Fusion, which offers free and paid access to content and data for consumer-facing enterprise use through publicly available APIs. In addition, it provides content licensing, as well as allows third-party data providers to update and manage business listing information on behalf of businesses. Further, the company offers its products directly through its sales force; indirectly through partners; and online through its website and business app, as well as non-advertising partner arrangements. It has partnership with Grubhub for providing consumers with a service to place food orders for pickup and delivery. The company was incorporated in 2004 and is headquartered in San Francisco, California.

Earnings Per Share

As for profitability, Yelp has a trailing twelve months EPS of $0.59.

PE Ratio

Yelp has a trailing twelve months price to earnings ratio of 71.77. Meaning, the purchaser of the share is investing $71.77 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Yelp’s EBITDA is 49.16.

Sales Growth

Yelp’s sales growth is 10.3% for the ongoing quarter and 9.4% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 169.2% and 50%, respectively.

Previous days news about Yelp(YELP)

  • According to Zacks on Monday, 30 October, "The rapid adoption of cloud computing, improving Internet speed and penetration, rapid adoption of 4G Volte technology, augmented/virtual reality, increasing demand for over-the-top videos and an expanding user base are likely to have remained major tailwinds for Internet companies like DoorDash (DASH Quick QuoteDASH – Free Report) , PayPal (PYPL Quick QuotePYPL – Free Report) , Wayfair (W Quick QuoteW – Free Report) and Yelp (YELP Quick QuoteYELP – Free Report) .", "San Francisco, CA-based Yelp is scheduled to report third-quarter 2023 results on Nov 2. "

7. Vertex Pharmaceuticals (VRTX)

9.1% sales growth and 24.56% return on equity

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO and SYMDEKO/SYMKEVI for people with CF with at least one F508del mutation for 6 years of age or older; ORKAMBI for CF homozygous F508del mutation for CF patients 2 year or older; and KALYDECO for the treatment of patients with 4 months or older who have CF with a mutation that is responsive to ivacaftor, and R117H mutation or one of certain gating mutations. The company's pipeline includes VX-522, a CF mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial; and VX-864 for treatment of AAT deficiency, which is in Phase 2 clinical trial. In addition, it provides VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sell the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies or pharmacy chains, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Affinia Therapeutics; Arbor Biotechnologies, Inc.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Obsidian Therapeutics, Inc.; Verve Therapeutics; Skyhawk Therapeutics; and Ribometrix, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Earnings Per Share

As for profitability, Vertex Pharmaceuticals has a trailing twelve months EPS of $12.93.

PE Ratio

Vertex Pharmaceuticals has a trailing twelve months price to earnings ratio of 29.04. Meaning, the purchaser of the share is investing $29.04 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.56%.

Volume

Today’s last reported volume for Vertex Pharmaceuticals is 542468 which is 43.1% below its average volume of 953465.

Previous days news about Vertex Pharmaceuticals(VRTX)

  • According to MarketWatch on Wednesday, 1 November, "Crispr Therapeutics AG’s stock CRSP rallied 17% in premarket trade Wednesday, after a positive meeting of a Food and Drug Administration advisory panel on the gene-editing drug exa-cel developed by Crispr and partner Vertex Pharmaceuticals VRTX as a treatment for sickle-cell disease. "
  • According to MarketWatch on Wednesday, 1 November, "Crispr Therapeutics AG’s stock CRSP rallied 17% in premarket trade Wednesday, after a positive meeting of a Food and Drug Administration advisory panel on the gene-editing drug exa-cel developed by Crispr and partner Vertex Pharmaceuticals VRTX as a treatment for sickle-cell disease. "

8. Vulcan Materials Company (VMC)

5.4% sales growth and 11.68% return on equity

Vulcan Materials Company, together with its subsidiaries, produces and supplies construction aggregates primarily in the United States. It operates through four segments: Aggregates, Asphalt, Concrete, and Calcium. The Aggregates segment provides crushed stones, sand and gravel, sand, and other aggregates; and related products and services that are applied in construction and maintenance of highways, streets, and other public works, as well as in the construction of housing and commercial, industrial, and other nonresidential facilities. The Asphalt Mix segment offers asphalt mix in Alabama, Arizona, California, New Mexico, Tennessee, and Texas, as well as engages in the asphalt construction paving activity in Alabama, Tennessee, and Texas. The Concrete segment provides ready-mixed concrete in California, Maryland, New Jersey, New York, Oklahoma, Pennsylvania, Texas and Virginia, and Washington D.C. The Calcium segment mines, produces, and sells calcium products for the animal feed, plastics, and water treatment industries. The company was formerly known as Virginia Holdco, Inc. and changed its name to Vulcan Materials Company. Vulcan Materials Company was founded in 1909 and is headquartered in Birmingham, Alabama.

Earnings Per Share

As for profitability, Vulcan Materials Company has a trailing twelve months EPS of $6.26.

PE Ratio

Vulcan Materials Company has a trailing twelve months price to earnings ratio of 33.36. Meaning, the purchaser of the share is investing $33.36 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.68%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 27.5% and 33.3%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *